Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
PaperCitations, authors & open-access status
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 83 citations, 2023 year and green oa status.
83
Citations
2023
Year
green
OA Status